Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
1.090
0.00 (0.01%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Eyenovia Statistics

Total Valuation

Eyenovia has a market cap or net worth of $3.09 million. The enterprise value is $12.21 million.

Market Cap 3.09M
Enterprise Value 12.21M

Important Dates

The last earnings date was Tuesday, April 15, 2025, after market close.

Earnings Date Apr 15, 2025
Ex-Dividend Date n/a

Share Statistics

Eyenovia has 2.83 million shares outstanding. The number of shares has increased by 62.41% in one year.

Current Share Class 2.83M
Shares Outstanding 2.83M
Shares Change (YoY) +62.41%
Shares Change (QoQ) +39.64%
Owned by Insiders (%) 0.22%
Owned by Institutions (%) 2.68%
Float 2.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 15.84
Forward PS 0.98
PB Ratio -0.24
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 212.87
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.17

Current Ratio 0.17
Quick Ratio 0.15
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -15.11

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -144.58%
Return on Invested Capital (ROIC) -201.99%
Return on Capital Employed (ROCE) 303.19%
Revenue Per Employee $4,095
Profits Per Employee -$3.56M
Employee Count 14
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -97.36% in the last 52 weeks. The beta is 1.20, so Eyenovia's price volatility has been higher than the market average.

Beta (5Y) 1.20
52-Week Price Change -97.36%
50-Day Moving Average 1.41
200-Day Moving Average 28.14
Relative Strength Index (RSI) 38.34
Average Volume (20 Days) 48,349

Short Selling Information

The latest short interest is 123,238, so 4.35% of the outstanding shares have been sold short.

Short Interest 123,238
Short Previous Month 138,241
Short % of Shares Out 4.35%
Short % of Float 4.36%
Short Ratio (days to cover) 0.27

Income Statement

In the last 12 months, Eyenovia had revenue of $57,336 and -$49.82 million in losses. Loss per share was -$59.81.

Revenue 57,336
Gross Profit -8.73M
Operating Income -37.53M
Pretax Income -32.44M
Net Income -49.82M
EBITDA -36.40M
EBIT -37.53M
Loss Per Share -$59.81
Full Income Statement

Balance Sheet

The company has $2.12 million in cash and $11.24 million in debt, giving a net cash position of -$9.12 million or -$3.22 per share.

Cash & Cash Equivalents 2.12M
Total Debt 11.24M
Net Cash -9.12M
Net Cash Per Share -$3.22
Equity (Book Value) -13.10M
Book Value Per Share -8.69
Working Capital -13.28M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$30.12 million and capital expenditures -$161,477, giving a free cash flow of -$30.28 million.

Operating Cash Flow -30.12M
Capital Expenditures -161,477
Free Cash Flow -30.28M
FCF Per Share -$10.70
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -65,456.83%
Pretax Margin -86,888.57%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Eyenovia does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -62.41%
Shareholder Yield -62.41%
Earnings Yield -1,614.56%
FCF Yield -981.42%

Analyst Forecast

The average price target for Eyenovia is $2.00, which is 83.47% higher than the current price. The consensus rating is "Hold".

Price Target $2.00
Price Target Difference 83.47%
Analyst Consensus Hold
Analyst Count 4
Revenue Growth Forecast (5Y) 308.45%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on February 3, 2025. It was a reverse split with a ratio of 0.0125:1.

Last Split Date Feb 3, 2025
Split Type Reverse
Split Ratio 0.0125:1

Scores

Eyenovia has an Altman Z-Score of -110.92 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -110.92
Piotroski F-Score 1